These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22207651)

  • 41. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24.
    Fitzgerald N; Cross M; O'Shea S; Fox J
    Sex Transm Infect; 2017 Mar; 93(2):100-101. PubMed ID: 27272704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2.
    Beelaert G; Fransen K
    J Virol Methods; 2010 Sep; 168(1-2):218-22. PubMed ID: 20561542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid, real-time detection of acute HIV infection in patients in Africa.
    Fiscus SA; Pilcher CD; Miller WC; Powers KA; Hoffman IF; Price M; Chilongozi DA; Mapanje C; Krysiak R; Gama S; Martinson FE; Cohen MS;
    J Infect Dis; 2007 Feb; 195(3):416-24. PubMed ID: 17205481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.
    Piwowar-Manning E; Fogel JM; Richardson P; Wolf S; Clarke W; Marzinke MA; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Clin Virol; 2015 Jan; 62():75-9. PubMed ID: 25542477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.
    Stekler JD; O'Neal JD; Lane A; Swanson F; Maenza J; Stevens CE; Coombs RW; Dragavon JA; Swenson PD; Golden MR; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e119-22. PubMed ID: 24342471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity and specificity of the new Bio-Rad HIV screening test, Access HIV combo V2.
    Guiraud V; Ciczora Y; Cardona M; Defer C; Gréaume S; Nogues D; Gautheret-Dejean A
    J Clin Microbiol; 2024 May; 62(5):e0009524. PubMed ID: 38534108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations.
    Nasrallah GK; Al-Buainain R; Younes N; Dargham SR; Al-Sadeq DW; Elhassan M; Al-Shaar I; Yassine HM; Abu-Raddad LJ; Emara MM; Ismail A
    PLoS One; 2023; 18(2):e0278079. PubMed ID: 36749795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay.
    Mühlbacher A; Schennach H; van Helden J; Hebell T; Pantaleo G; Bürgisser P; Cellerai C; Permpikul P; Rodriguez MI; Eiras A; Alborino F; Cunningham P; Axelsson M; Andersson S; Wetlitzky O; Kaiser C; Möller P; de Sousa G
    Med Microbiol Immunol; 2013 Feb; 202(1):77-86. PubMed ID: 22706797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the performance of a new automated HIV combination assay.
    Ghisetti V; Coignard C; Allice T; Thoai Duong L
    J Clin Virol; 2017 Nov; 96():80-83. PubMed ID: 29020658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening Yield of HIV Antigen/Antibody Combination and Pooled HIV RNA Testing for Acute HIV Infection in a High-Prevalence Population.
    Peters PJ; Westheimer E; Cohen S; Hightow-Weidman LB; Moss N; Tsoi B; Hall L; Fann C; Daskalakis DC; Beagle S; Patel P; Radix A; Foust E; Kohn RP; Marmorino J; Pandori M; Fu J; Samandari T; Gay CL
    JAMA; 2016 Feb; 315(7):682-90. PubMed ID: 26881371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective study in three regions of the United States.
    Pandori MW; Westheimer E; Gay C; Moss N; Fu J; Hightow-Weidman LB; Craw J; Hall L; Giancotti FR; Mak ML; Madayag C; Tsoi B; Louie B; Patel P; Owen SM; Peters PJ
    J Clin Virol; 2013 Dec; 58 Suppl 1():e92-6. PubMed ID: 24342485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection.
    Cárdenas AM; Baughan E; Hodinka RL
    J Clin Virol; 2013 Dec; 58 Suppl 1():e97-e103. PubMed ID: 24113294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Programmatic evaluation of a combined antigen and antibody test for rapid HIV diagnosis in a community and sexual health clinic screening programme.
    Taegtmeyer M; MacPherson P; Jones K; Hopkins M; Moorcroft J; Lalloo DG; Chawla A
    PLoS One; 2011; 6(11):e28019. PubMed ID: 22132195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.